Clovis Oncology's Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk Subgroups
Stock Information for Clovis Oncology Inc.
Loading
Please wait while we load your information from QuoteMedia.